Yingying Chen

Hefei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Correction: Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities.

Correction: Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities.

Journal: Cancer cell international

Published: October 28, 2025

CSRP1 is a potential therapeutic targets for DLBCL: A computational analysis and in vitro experiments.

CSRP1 is a potential therapeutic targets for DLBCL: A computational analysis and in vitro experiments.

Journal: Clinical and experimental medicine

Published: June 05, 2025

Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities.

Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities.

Journal: Cancer cell international

Published: November 01, 2024

Meta-analysis on the effectiveness and safety of venetoclax-based combination therapy with hypomethylation in acute myeloid leukemia.

Meta-analysis on the effectiveness and safety of venetoclax-based combination therapy with hypomethylation in acute myeloid leukemia.

Journal: European journal of medical research

Published: August 15, 2024

AML with RUNX1::RUNX1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR.

AML with RUNX1::RUNX1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR.

Journal: Clinical laboratory

Published: March 12, 2024

Synergistic effect of venetoclax and ibrutinib on ibrutinib-resistant ABC-type DLBCL cells.

Synergistic effect of venetoclax and ibrutinib on ibrutinib-resistant ABC-type DLBCL cells.

Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica

Published: February 23, 2024

Decoding prognostic factors in SARS-CoV-2 complications among patients with hematological disorders.

Decoding prognostic factors in SARS-CoV-2 complications among patients with hematological disorders.

Journal: Clinics (Sao Paulo, Brazil)

Published: December 20, 2023

Knowledge, attitude, and practice toward leukemia in the general population and among family members of patients with leukemia: A cross-sectional study.

Knowledge, attitude, and practice toward leukemia in the general population and among family members of patients with leukemia: A cross-sectional study.

Journal: Heliyon

Published: September 25, 2023

Advances and Challenges in the Investigation of Metastasis in Diffuse Large B-Cell Lymphoma.

Advances and Challenges in the Investigation of Metastasis in Diffuse Large B-Cell Lymphoma.

Journal: Mini reviews in medicinal chemistry

Published: December 07, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026